Principles for 3D/4D QSAR classification of drugs

Drug Discovery Today

Volumn 13, Issue 21-22, 2008, Pages 952-959

  Potemkin, Vladimir ^a   Grishina, Maria ^a  

^a CHELYABINSK STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; CYCLIN DEPENDENT KINASE 2 INHIBITOR; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIHYDROFOLATE REDUCTASE INHIBITOR; DRUG RECEPTOR; LIGAND; LIPOXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; THERMOLYSIN; TUBERCULOSTATIC AGENT;

COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG ACTIVITY; DRUG ADSORPTION; DRUG BINDING SITE; DRUG CLASSIFICATION; DRUG CONFORMATION; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG TARGETING; FOUR DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATION; MOLECULAR DOCKING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; THREE DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGORITHMS; ANIMALS; HUMANS; MODELS, STATISTICAL; MOLECULAR CONFORMATION; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54049156024     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.07.006     Document Type: Review

References (44)

1. Zupan J., and Gasteiger J. Neural Networks in Chemistry and Drug Design: An Introduction (1999), Wiley
2. Tetko I.V., et al. Pharmaceutical fingerprinting in phase space. 2. Pattern recognition. Anal. Chem. 71 (1999) 2431-2439
3. In: Cruciani G., Mannhold R., Kubinyi H., and Folkers G. (Eds). Molecular Interaction Fields: Applications in Drug Discovery and ADME Prediction (2005), Wiley
4. Schneider G., Baringhaus K.-H., and Kubinyi H. Molecular Design: Concepts and Applications (2008), Wiley
5. Qin L., et al. Genetic algorithm based neural classifiers for factor subset extraction. Soft Comput. Fusion Found. Methodol. Applic. 12 (2008) 623-632
6. El-Solh A., et al. Predicting active pulmonary tuberculosis using an artificial neural network. Medinfo 116 (2004) 968-973
7. Zhang P., et al. Neural vs. statistical classifier in conjunction with genetic algorithm based feature selection. Pattern Recognit. Lett. 26 (2005) 909-919
8. Khandelwal A., et al. Computational models to assign biopharmaceutics drug disposition classification from molecular structure. Pharm. Res. 24 (2007) 2249-2262
9. Deconinck E., et al. Classification tree models for the prediction of blood-brain barrier passage of drugs. J. Chem. Inf. Model. 46 (2006) 1410-1419
10. Givehchi A., et al. Impact of descriptor vector scaling on the classification of drugs and nondrugs with artificial neural networks. J. Mol. Mod. 10 (2004) 204-211
11. Breneman C.M., et al. New developments in PEST shape/property hybrid descriptors. J. Comput. Aid. Mol. Des. 17 (2004) 231-240
12. Gramatica P. WHIM descriptors of shape. QSAR Combinat. Sci. 25 (2006) 327-332
13. Manoj K.P., et al. Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptors. Chem. Pharm. Bull. 54 (2006) 1586-1591
14. Meek P.J., et al. Shape signatures: speeding up computer aided drug discovery. Drug Discov. Today 11 (2006) 895-904
15. Advanced CoMFA, Tripos
16. QSAR with CoMFA, Tripos
17. Von Itzstein M., et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 (1993) 418-423
18. Vedani A., et al. Simulating α/β selectivity at the human thyroid hormone receptor: consensus scoring using multidimensional QSAR. ChemMedChem 2 (2006) 78-87
19. Kasabov N. Global, local and personalised modeling and pattern discovery in bioinformatics: an integrated approach. Pattern Recognit. Lett. 28 (2007) 673-685
20. Davies E.K., et al. Pattern recognition and massively distributed computing. Int. J. Comput. Chem. 23 (2002) 1544-1550
21. Papa E., et al. Prediction of PAH mutagenicity in human cells by QSAR classification. SAR QSAR Environ. Res. 19 (2008) 115-127
22. Ohgaru T., et al. Ordinal classification using comparative molecular field analysis. J. Chem. Inf. Model. 48 (2008) 207-212
23. Van Drie J.H. Pharmacophore discovery - lessons learned. Curr. Pharm. Des. 9 (2003) 1649-1664
24. Bohr N.H.D. On the notions of causality and complementarity. Dialectica 2 (1948) 312-319
25. Potemkin V.A., et al. An alternative method for 3D-QSAR and the alignment of molecular structures: BiS (Biological Substrate Search). In: Holtje H.-D., and Sippl W. (Eds). Rational Approaches to Drug Design (2001), Prous Science Publishers 349-353
26. Potemkin V.A., et al. Quantitative relationship between structure and antibacterial activity of quinolone derivatives. Pharm. Chem. J. 36 (2002) 22-25
27. Potemkin V.A., et al. Multiconformational method for analyzing the biological activity of molecular structures. J. Struct. Chem. 43 (2002) 1045-1049
28. Mikuchina K., et al. 3D QSAR analysis and pharmacophore modelling of p38 MAP kinase inhibitors using BiS algorithm. Arch. Pharm. Pharm. Med. Chem. 335 (2002) C74
29. Potemkin V.A., et al. Theoretical investigation of the antituberculous activity of membranotropic podands. Pharm. Chem. J. 37 (2003) 468-472
30. Grishina M.A., et al. Theoretical study of the substrate specificity of cytochrome P-450 isoforms. Pharm. Chem. J. 39 (2005) 509-513
31. Potemkin V.A., et al. Modeling of drug molecules orientation within a receptor cavity in the BiS algorithm framework. J. Struct. Chem. 48 (2007) 155-160
32. Grishina M.A., et al. A novel techniques for virtual discovery for study of multistage bioprocesses. Drugs Future 32 Suppl. A (2007) 27
33. Pereyaslavskaya E.S., et al. The analysis of pharmacophoric parts of DHFR - inhibitors using 3D-QSAR algorithm BiS/MC and X-ray data. Drugs Future 32 Suppl. A (2007) 87
34. Grishina M.A., et al. A novel approach to pattern recognition for drugs. Drugs Future 32 Suppl. A (2007) 112
35. Potemkin V.A., et al. A new paradigm for pattern recognition of drugs. J. Comput. Aid. Mol. Des. (2008). http://www.springerlink.com 10.1007/s10822-008-9203-x
36. Potemkin V.A., et al. A new approach to predicting the thermodynamic parameters of substances from molecular characteristics. Rus. J. Phys. Chem. A 70 (1996) 411-415
37. Bartashevich E.V., et al. Method for multiconformational modeling of the three dimensional shape of a molecule. J. Struct. Chem. 43 (2002) 1033-1039
38. Harrington E.C. The desirability function. Ind. Qual. Control 21 (1965) 494-498
39. Hsieh K.-L., et al. Optimization of a multi-response problem in Taguchi's dynamic system. Comput. Ind. Eng. 49 (2005) 556-571
40. Cosgrove D.A., et al. A novel method of aligning molecules by local surface shape similarity. J. Comput. Aid. Mol. Des. 14 (2000) 573-591
41. Geronikaki A.A., et al. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. J. Med. Chem. 51 (2008) 1601-1609
42. Geronikaki A.A., et al. Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb. Chem. High Throughput Screen. 9 (2006) 425-442
43. Herron D.K., et al. 1,2-Dibenzamidobenzene inhibitors of human factor Xa. J. Med. Chem. 43 (2000) 859-872
44. 2-aroylanthranilamide inhibitors of human factor Xa. J. Med. Chem. 43 (2000) 873-882